← Back to Clinical Trials
Recruiting NCT07511842

NCT07511842 REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07511842
Status Recruiting
Phase
Sponsor Université de Sherbrooke
Condition Total Knee Arthroplasty
Study Type INTERVENTIONAL
Enrollment 106 participants
Start Date 2026-03-03
Primary Completion 2027-12-31

Trial Parameters

Condition Total Knee Arthroplasty
Sponsor Université de Sherbrooke
Study Type INTERVENTIONAL
Phase N/A
Enrollment 106
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2026-03-03
Completion 2027-12-31
Interventions
Knee Extension Brace (Zimmer-type)Early Mobilization (Standard Care)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Postoperative pain following total knee arthroplasty (TKA) is often difficult to manage, particularly with the increasing use of outpatient surgery where patients recover at home. This study aims to evaluate whether wearing a knee extension brace for the first 72 hours after surgery can reduce pain and improve recovery. This pilot randomized controlled trial will compare two groups of patients undergoing primary unilateral TKA: one group will wear an extension brace continuously for 72 hours after surgery, while the control group will follow standard care with early mobilization. Participants will be followed for up to 12 months. The primary objective of this pilot study is to assess the feasibility of conducting a larger trial, including recruitment rates, adherence to the intervention, follow-up completion, safety, and acceptability. Clinical outcomes will also be explored, including pain at 2 and 6 weeks after surgery (measured using a visual analog scale), knee function, range of motion, opioid consumption, complications, healthcare use, and quality of life. The study hypothesizes that short-term immobilization of the knee in full extension will reduce postoperative pain and may improve early recovery outcomes. Findings from this pilot study will inform the design of a larger definitive trial and may contribute to improving postoperative care and pain management after knee replacement surgery.

Eligibility Criteria

Inclusion Criteria: * Person undergoing primary unilateral TKA for knee osteoarthritis at CHUS Exclusion Criteria: * Known thrombophilia or bleeding disorders * History of thromboembolic events * Contraindications to brace use (e.g., material allergy) * Revision or constrained knee prostheses * Use of continuous postoperative nerve block infusion

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology